LA's Wildfire Disaster, Zuck Flips on Free Speech, Why Trump Wants Greenland
Jan. 11, 2025, 2:08 a.m.
ASML's Strategy to Extend Moore's Law
Jan. 7, 2025, 9:50 a.m.
OpenAI says it knows how to make superintelligence now
Jan. 7, 2025, 1:32 a.m.
Comparing the Financials of Databricks and Snowflake
Dec. 30, 2024, 11:35 p.m.
The Future of TV or Just Another Netflix Hit?
Dec. 19, 2024, 12:10 a.m.
Ep. 274 - 2025 Biotech Preview: Markets, Catalysts and AI
Jan. 22, 2025, 8:41 p.m.
Ep. 273 - JPM 2025 Wrap: Sunny Skies & Megarounds
Jan. 17, 2025, 8:41 p.m.
Ep. 272 - JPM Deal Buzz & Rep. Auchincloss’ Take on Biopharma
Jan. 14, 2025, 8:41 p.m.
Ep. 271 - Biotech in the New Year. Plus: Beyond Biosecure
Jan. 7, 2025, 8:41 p.m.
Ep. 270 - Temple’s FDA Legacy. Plus: Chinese Innovation & Novo Obesity Data
Dec. 31, 2024, 8:41 p.m.
Bonus Content - Trends in Global Biopharma Deals: Lazard’s Kingston and Raine
Dec. 23, 2024, 8:41 p.m.
Ep. 269 - Trends in VC Funds, Obesity Start-ups and More
Dec. 17, 2024, 8:41 p.m.
Ep. 268 - Biosecure Setback & Novartis' $1B PTC Deal
Dec. 10, 2024, 8:41 p.m.
Ep. 267 - Trump's NIH Pick & Multi-targeted CAR Ts
Dec. 3, 2024, 8:41 p.m.
Ep. 266 - Jefferies Recap, FDA Commissioner & Biosecure Update
Nov. 26, 2024, 8:41 p.m.
Ep. 265 - RFK Jr. & HHS, Blenrep's Comeback, China Deals
Nov. 19, 2024, 8:41 p.m.
Ep. 264 - Prepping for Trump & Alzheimer's Ethics
Nov. 12, 2024, 8:41 p.m.
Ep. 263 - Alzheimer Insights: Anti-Amyloid Safety & Tau Teaser
Nov. 6, 2024, 8:41 p.m.
Ep. 262 - EGFR Case Study, FDA & Politics
Oct. 29, 2024, 8:41 p.m.
Ep. 261 - China Summit: Reinventing Your China Strategy
Oct. 24, 2024, 8:41 p.m.
Ep. 260 - VC Funds, New Chapter for MS, Wave's Data
Oct. 22, 2024, 8:41 p.m.
Ep. 259 - Causal Biology and Big Data, Ultra-Rare Drugs at FDA
Oct. 19, 2024, 8:41 p.m.
Ep. 258 - Breaking the Bear: 4Q Public Markets Preview
Oct. 7, 2024, 8:07 p.m.
Ep. 257 - Schizophrenia, Sickle Cell Drugs, D.C. Update
Sept. 30, 2024, 6:01 p.m.
Ep. 256 - ESMO Recap: Keeping TIGIT Alive, Rybrevant & Immunotherapy Anniversary
Sept. 25, 2024, 6:18 a.m.
Ep. 255 - Pediatric PRVs, Biosecure & Novo's Obesity Miss
Sept. 23, 2024, 5:10 a.m.
Ep. 254 - Takeaways from Grand Rounds 2024
Sept. 21, 2024, 4:07 a.m.
Ep. 253 - IPOs, GLP-1 & Obesity, AI & Biotech
Sept. 17, 2024, 2:09 a.m.
Ep. 252 - Akeso's Bispecific, Vaxcyte & Woodcock's Quality Mindset
Sept. 9, 2024, 10:53 p.m.
Ep. 251 - Eyes on the target: a Back to School Overview
Sept. 6, 2024, 9:35 p.m.